Clicky

OPKO Health Inc.(OPK) News

Date Title
Jun 29 OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025
Jun 25 OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
Jun 24 Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT
Jun 13 Here's Why You Should Retain OPKO Health Stock in Your Portfolio
Jun 9 OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
May 17 Strong week for OPKO Health (NASDAQ:OPK) shareholders doesn't alleviate pain of three-year loss
May 15 OPKO Health to Participate in Two Upcoming Investor Conferences
Apr 17 OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
Apr 16 OPKO Health, Inc. (NASDAQ:OPK) boasts of bullish insider sentiment with 52% ownership and they have been buying lately
Mar 14 Tesla Stock Is Reaching a Breaking Point, Analyst Says. Plus, Vertical Aerospace, OPKO Health, and More.
Mar 14 Is OPKO Health, Inc. (OPK) The Best Stock Under $3 to Buy Now?
Mar 14 Labcorp is Set to Acquire Select Assets of BioReference Health of OPK
Mar 12 Labcorp to acquire certain assets of Opko Health’s BioReference Health
Mar 12 Truist remains bullish on Labcorp after ‘another nice strategic acquisition’
Mar 11 Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Feb 13 OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
Feb 12 Is Opko Health Inc. (OPK) the Best Nasdaq Stock Under $5 to Buy?
Oct 7 NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan
Oct 7 ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
Sep 26 ENTX & OPK Stock May Gain Following Positive PK/PD Research Data